Reduced expression of branched‐chain amino acid transferase 1 (BCAT1) in IDH1‐mutated gliomas has been shown, in part, to be caused by hypermethylation of the BCAT1 promoter region. This evidence concerns the gene BCAT1 and central nervous system cancer.